Curebase

Advancing AI to eliminate trial and error in medicine. Our digital twins enable confident and quick clinical trials. We work in neuroscience, immunology, metabolic disease, and more. TwinRCTs reach full enrollment sooner because they require fewer patients to achieve the same power as traditional trial designs. Shorten time to enrollment in late-stage studies. TwinRCTs improve the ability to observe treatment effects in early-stage studies by increasing power without adding more patients. Make confident decisions from early-stage studies and attract study participants. TwinRCTs give participants a greater chance of receiving the experimental treatment because they use smaller control groups. Position clinical trials with digital twins for regulatory success. Unlearn is engineering the future of medicine with artificial intelligence. We invent and deploy new types of generative models trained on extensive patient-level data from previous studies.

Science 37 is a clinical research company specializing in decentralized clinical trials through its Metasite model, which eliminates physical proximity as a barrier, enabling patients to participate from anywhere. This approach expands access to over 90% of patients who are unable to participate in traditional site-based research, offering the recruiting power of 20 sites in one and providing the flexibility patients need to participate from anywhere. The Metasite is powered by a proprietary platform that drives uniform study orchestration, guiding the workflow of patients and study staff, and capturing study data without the need for manual reentry. This centralization of people, processes, and platforms delivers built-in protocol compliance, ensuring greater compliance and high-quality data. Science 37's in-house medical teams, telemedicine investigators, and mobile nurses have extensive experience in remote trial conduct across various therapeutic areas, ensuring broad reach.